Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Barium to InRule
Mandate

Vinge advises on the sale of Barium to InRule

September 01, 2021 M&A

Vinge has advised Nidoco AB and other shareholders in connection with the sale of Barium AB to InRule Technology, Inc.

Barium is a SaaS company which assists organisations and employees to improve efficiency and to future‑proof their working methods and processes by offering an innovative web service where smart IT support and applications can be created so that the operations can be followed up, maintained and easily improved.

Vinge’s team primarily consisted of Johan Winnerblad, Desirée Hagenfeldt, Anna Thoms, Gustav Persson, Amanda Steen, Nathalie Hughes, Christoffer Widström and Viktoria Owetz Leyva.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026